An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Internal ...